Patent · US Active

Treatments for Mycobacterium tuberculosis

US9925251B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

President and Fellows of Harvard College · US

Inventors

Tatos Akopian · Dedham, US
Olga Kandror · Newton, US
Alfred L. Goldberg · Sharon, US
Ravikiran M. Raju · Cambridge, US
Meera Unnikrishnan · Siena, IT
Eric Rubin · Newton, US

Key dates

Filing date	Oct 19, 2012
Grant date	Mar 27, 2018
Priority date	—
Expiry date	Mar 11, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The technology described herein relates to treatments for tuberculosis which target the ClpP1P2 protease complex, including ClpC1. Further embodiments relate to assays and screens for modulators of the ClpP1P2 protease complex, including ClpC1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.